Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Copper to Zinc Ratio on Outcome of End Stage Renal Disease Patients

NCT07109778 is registered in ClinicalTrials.gov with Minia University as lead sponsor.

NCT NCT07109778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07109778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Copper to Zinc Ratio on Outcome of End Stage Renal Disease Patients
Lead sponsor
Minia University
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
April 1, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

control condition, esrd (end stage renal disease)